United KingdomResearch and clinical trials
Data from England: in pyruvate kinase deficiency, the risk of death is five times higher than in peers
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
In England, 89 patients with pyruvate kinase deficiency were identified from health records. Each was compared with five people of similar age and sex. The risk of death was about five times higher in patients. Gallbladder problems were much more common in patients. The study was carried out with support from a drug company.
What does it mean for patients and families?
This disease means not only anemia but also long-term problems. Regular monitoring of gallbladder, spleen, and heart health is important. Treatment and follow-up are planned with the doctor.
Source
Scientific paper: Overall Survival of Patients With Pyruvate Kinase Deficiency in the UK: A Real-World Study. EJHaem, 2025. DOI: 10.1002/jha2.70009 · PubMed 40034869
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Pyruvate kinase deficiency
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.